Key Points
- ADARx Pharmaceuticals director Simeon George bought 1.6 million shares at $17 each, investing a total of $27.2 million.
- The purchase increased George’s holdings by 40.46% to 5.55 million shares, worth approximately $94.4 million after the transaction.
- ADRX shares opened at $20.64 and were reported up 2.7%; the clinical-stage biopharmaceutical company develops RNA-based treatments for immune-mediated and other serious diseases.
ADARx Pharmaceuticals, Inc. (NASDAQ:ADRX - Get Free Report) Director Simeon George purchased 1,600,000 shares of the stock in a transaction on Monday, September 28th. The shares were purchased at an average cost of $17.00 per share, with a total value of $27,200,000.00. Following the transaction, the director owned 5,554,094 shares of the company's stock, valued at $94,419,598. This trade represents a 40.46% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
ADARx Pharmaceuticals Trading Up 2.7%
Shares of NASDAQ:ADRX opened at $20.64 on Wednesday. ADARx Pharmaceuticals, Inc. has a 12 month low of $18.50 and a 12 month high of $23.21.
ADARx Pharmaceuticals Company Profile
(
Get Free Report)
ADARx Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company focused on developing RNA-based medicines for immune-mediated and other serious diseases. The company is headquartered in San Diego, California, and uses proprietary technologies designed to modulate disease-related proteins at the RNA level.
ADARx's pipeline includes investigational therapies intended to address conditions involving the complement system, coagulation pathways and other biologic mechanisms. Its programs are designed to provide targeted, durable treatment through approaches such as RNA interference and related forms of RNA-based therapeutic intervention.
Founded in 2018, ADARx has advanced its drug candidates through preclinical and clinical development and has pursued regulatory and clinical activities in the United States and other international markets.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
